JOSEPH HOBBS: Open Payments
NPI 1700963097 · LINCOLN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 49 payments from 21 companies in 2025. Trend: 2023 $1,965 · 2024 $1,580 · 2025 $1,465
Food & beverage: $1,465
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $305 |
| Lilly USA, LLC | 5 | $161 |
| SI-BONE, INC. | 1 | $137 |
| PFIZER INC. | 6 | $130 |
| Providence Medical Technology, Inc. | 1 | $119 |
| Otsuka America Pharmaceutical, Inc. | 1 | $101 |
| Exact Sciences Corporation | 3 | $80 |
| ALK-Abello, Inc | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
Products named: Ozempic, Rybelsus, REXULTI, NURTEC ODT, Odactra, The Cologuard Plus Collection Kit, TRINTELLIX, ZENPEP.
Industry payments across CA — which companies pay providers there.
